Recombinant Human Antibody (LTM14) is capable of binding to S. aureus Alpha-hemolysin , expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-S. aureus Alpha-hemolysin mAb and CH1-3 region of human IgG and a light chain (LC) encoding VL from anti-S. aureus Alpha-hemolysin proteins mAb and CL of human kappa light chain. Exists as a disulfide linked dimer of the HC and LC hetero-dimer under non-reducing condition. The epitope of LTM14 is centered on α-hemolysin residue R66, which has been implicated in binding to the eukaryotic membrane.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PFBZ-177 | Recombinant Human Anti-S. aureus Alpha-hemolysin Antibody Fab Fragment (LTM14) | ELISA | Fab |
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.